Arbutus Biopharma Corp. (ABUS)
4.22
-0.07
(-1.63%)
USD |
NASDAQ |
Oct 16, 16:00
4.22
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Research and Development Expense (Annual) : 25.24M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 25.24M |
| December 31, 2024 | 54.04M |
| December 31, 2023 | 73.70M |
| December 31, 2022 | 84.41M |
| December 31, 2021 | 65.50M |
| December 31, 2020 | 47.48M |
| December 31, 2019 | 57.60M |
| December 31, 2018 | 57.95M |
| December 31, 2017 | 62.68M |
| December 31, 2016 | 55.25M |
| December 31, 2015 | 47.30M |
| December 31, 2014 | 38.71M |
| December 31, 2013 | 21.46M |
| December 31, 2012 | 18.04M |
| December 31, 2011 | 20.11M |
| Date | Value |
|---|---|
| December 31, 2010 | 21.49M |
| December 31, 2009 | 15.58M |
| December 31, 2008 | 15.11M |
| December 31, 2007 | 7.777M |
| December 31, 2006 | 4.680M |
| December 31, 2005 | 8.534M |
| December 31, 2004 | 20.89M |
| December 31, 2003 | 21.95M |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 7.552M |
| December 31, 1998 | 8.970M |
| December 31, 1997 | 6.492M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gossamer Bio, Inc. | 174.07M |
| Legend Biotech Corp. | 415.80M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |